| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.078 | 0.08 |